Ischemic Heart Disease (IHD): Clinical Trials

2 trials for Ischemic Heart Disease (IHD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 enrolling by invitation. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Enrolling by invitation 1
Phase 31Enrolling by invitation 1

Follow Ischemic Heart Disease (IHD): new trials by email Literature Review of Ischemic Heart Disease (IHD) trials Research Report on Ischemic Heart Disease (IHD)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
atenolol, Metoprolol tartrate, Ivabradine - Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD)
Phase 2 / Phase 3Enrolling by invitationGødstrup Hospital3502025-12-152025-12-17
XTR003 PET Radiotracer for the Detection of Viable Myocardium
XTR003 - Ischemic Heart Disease (IHD)
Phase 2CompletedSinotau Pharmaceutical Group512021-12-152023-06-02

Narrower conditions

Myocardial Ischemia (2)  ·  Coronary Artery Disease (1)  ·  Non-ST Elevated Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Vascular Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Coronary Disease (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Myocardial Infarction (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Atenolol (1)  ·  Ivabradine (1)  ·  Metoprolol (1)

Sponsors

Gødstrup Hospital (1)  ·  Sinotau Pharmaceutical Group (1)

Countries

China (1)  ·  Denmark (1)

Top investigators

Simon Winther, MD, PhD (1)

NIH funding

2025 (1)